Microencapsulated sodium butyrate reduces the frequency of abdominal pain in patients with irritable bowel syndrome

Abstract

MSB as a supplemental therapy can reduce the frequency of selected clinical symptoms in patients with IBS, without significant influence on reducing symptom severity.